What is a paraganglioma?

A paraganglioma—also called a “para,” or a PG—is a type of neuroendocrine tumor that forms near clusters of nerve cells called ganglia. Although they’re frequently noncancerous, they can still cause problems. They’re found more frequently in people with genetic mutations usually passed on by parents.

At Penn Medicine, our expert endocrinology and neurosurgery specialists have years of experience with these rare neuroendocrine tumors. We can find answers, protect your health, and get you the individualized care you need. While many people have successful paraganglioma treatment with surgery, we offer a range of additional options for those who need more.

Understanding paragangliomas and related tumors

Many paragangliomas involve nerve cells called chromaffin cells—the same cells that can give rise to a related tumor called a pheochromocytoma. There are differences between the two types of chromaffin-related tumors:

  • Paragangliomas can occur in any area where there are ganglia or nerve endings for the sympathetic or parasympathetic (more common) nervous systems. They’re usually found in the abdomen, pelvis, or head and neck (head and neck PGLs). Parasympathetic paras are much less likely to secrete (release) hormones than sympathetic tumors.
  • Pheochromocytomas are found in the adrenal gland. Pheochromocytomas arise from sympathetic ganglia and usually release hormones related to the fight or flight response.

Other paragangliomas form in related cells called glomus cells, part of the parasympathetic nervous system. These tumors grow in the chest, neck, and at the bottom of the skull.

Most paragangliomas are slow-growing, benign (noncancerous), and confined to one spot when they’re found. However, even benign paragangliomas can pose a risk. If the tumors release hormones, for example, effects may include high blood pressure and other heart health problems.

Up to 25 percent of paragangliomas can be cancerous and eventually spread (metastasize), typically to the lymph nodes, lungs, liver, and bones. Metastatic paraganglioma may run in families and is often less aggressive than other metastatic cancers. Treatments are available to manage the tumor and control symptoms. People can live for decades with metastatic paraganglioma with a good quality of life.

Paraganglioma symptoms

Paragangliomas often get called the “great mimics” or “great masqueraders” because they can share symptoms with many other conditions.

Diagnosing paraganglioma

Sometimes paraganglioma is found during a scan done for another reason. In other cases, people come to us because of symptoms or known genetic variants in their families, or to confirm a previous diagnosis. Most people are diagnosed between ages 20 and 50.

If our team suspects paraganglioma, we recommend genetic testing to identify any related variants and help guide next steps. We also review your family history for related tumors or inherited conditions, use blood or urine tests to look for hormone-related markers, and perform imaging scans to locate tumors and understand how they are behaving.

Expert care from many angles

With a range of experts thoroughly reviewing cases together, our team ensures you receive the treatment recommendations most likely to help. We consider not just the immediate problem, but the months and years ahead. We always prioritize your preferences and quality of life, balancing treatment benefits with potential side effects.

Recognized expertise in rare neuroendocrine tumors

Pheo Para Alliance Center of Excellence badge

Paragangliomas and pheochromocytomas can be challenging, so you need a team of experts with experience diagnosing and treating these tumors. We run a focused program within Penn’s Neuroendocrine Tumor Program, caring for more than 200 people with these rare tumors each year.

When you come to our program, you’ll find:

  • Coordination: Our clinicians represent a range of specialties working closely together. Many serve on a weekly neuroendocrine tumor board. For paragangliomas in the head and neck, they’re joined by specialized oncologists, ENT surgeons, and neurosurgeons.
  • Expertise: All of our specialists have deep experience with paragangliomas. Many of our providers publish leading papers and give national talks, including for genetics, nuclear medicine, and symptom control.
  • Innovation: We offer clinical trials to improve care and develop new treatments. We also run a research effort to secure and analyze tumor samples to answer questions about paragangliomas and find new treatments. Learn more about neuroendocrine tumor research and clinical trials.
  • Center of Excellence: We hold a Center of Excellence designation from the Pheo Para Alliance, the leading advocacy and research organization for paragangliomas and pheochromocytomas. It recognizes our personalized care, range of specialists, and research projects. We’re one of only nine such centers in the world, seven in the U.S., and the only program east of the Appalachians.
  • Support: We try to make your experience as easy and stress-free as possible. A nurse coordinator oversees records, scheduling, and many other needs. Throughout your treatment, we offer a range of additional support for neuroendocrine tumors.
National Cancer Institute Designated Comprehensive Cancer Center badge on top of shot of hospital

Rated “exceptional” by The National Cancer Institute

Penn Medicine’s Abramson Cancer Center is a world leader in cancer research, patient care, and education. Our status as a national leader in cancer care is reflected in our continuous designation as a Comprehensive Cancer Center by the National Cancer Institute (NCI) since 1973, one of 7 such centers in the United States. The ACC is also a member of the National Comprehensive Cancer Network, one of a select few cancer centers in the U.S., that are working to promote equitable access to high-quality, advanced cancer care.

Related specialties

Schedule an appointment

We can help you schedule an appointment or you can search our directory of specialists.